含糊其辞
发表于 2025-3-28 17:17:12
http://reply.papertrans.cn/43/4209/420816/420816_41.png
Surgeon
发表于 2025-3-28 21:21:24
http://reply.papertrans.cn/43/4209/420816/420816_42.png
连系
发表于 2025-3-28 23:18:40
http://reply.papertrans.cn/43/4209/420816/420816_43.png
邪恶的你
发表于 2025-3-29 05:52:24
http://reply.papertrans.cn/43/4209/420816/420816_44.png
Pituitary-Gland
发表于 2025-3-29 07:21:56
Food Security and Agriculture Sector,esistance are discussed, with specific examples for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV). Prospects for new antiviral designs aimed at counteracting the adaptive potential of viral quasispecies are presented.
Redundant
发表于 2025-3-29 12:50:22
Drug Resistance in ,,ly endemic areas including amphotericin B, paromomycin, and miltefosine. This chapter is presenting our current understanding of the mode of action and underlying resistance mechanisms of the few therapeutic drugs used against ..
Allergic
发表于 2025-3-29 16:56:22
HBV Therapy and the Problem of Drug Resistance,drug resistance is an important clinical concern. In this chapter, we discuss the principles of HBV antiviral resistance and clinical pathways for preventing the selection of drug-resistant variants, as well as appropriate management strategies for antiviral treatment failure.
interrogate
发表于 2025-3-29 21:11:06
Quasispecies and Drug Resistance,esistance are discussed, with specific examples for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV). Prospects for new antiviral designs aimed at counteracting the adaptive potential of viral quasispecies are presented.
带子
发表于 2025-3-30 00:21:42
he microbe, but on the specific drug (target), are highly diverse, and are covered in great detail. This work also discusses and compares the biological, biochemical and structural aspects of resistance and its evolution..978-1-4939-0667-3
四海为家的人
发表于 2025-3-30 07:07:30
Paula Maurutto,Kelly Hannah-Moffatn but also in susceptibility to HIV-1 Vif-mediated degradation. The interplay between these intracellular host defenses and HIV counterstrategies is discussed in this chapter with a special emphasis on viral evolution and drug resistance.